DIS vs FGEN · P/E 16, rev $94.42B vs rev $29.6M
Walt Disney Company (DIS) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Josh D'Amaro.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
DIS currently screens at market cap $175.14B and trailing P/E 16.1. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the DIS and FGEN stock pages for the full models.
Not investment advice.